Analysts Set Globus Medical, Inc. (NYSE:GMED) Price Target at $94.00
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve research firms that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price […]
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve research firms that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price […]
